Skip to main content

Poor Health Outcomes of Older Cancer Patients in the UK: Is Age Discrimination at Play?

Age discrimination can have many negative effects on the livelihoods of older people. Among these effects are poor health outcomes in older Britons suffering from cancer, according to a recent report from the King’s Fund, a health think tank, and Cancer Research UK.

In 2004-2005, England was spending close to £4 billion on cancer care, its 4th largest health expenditure among 24 health conditions. Although England’s healthcare spending is similar to other European countries, its health outcomes are worse in older adults with cancer. The report titled “How to improve cancer survival: Explaining England’s relatively poor rates,” looks at why poor health outcomes exist among cancer patients.

The report shows that cancer survival rates in England are worse than in other countries due to late diagnosis, delayed treatment, and under-treatment in the older patient population. Age is considered an influential factor in delaying cancer diagnosis, and older cancer patients reportedly receive less evaluation by cancer specialists. When they do, they are oftentimes offered fewer treatment options as a result of “age bias”.

Is age bias reflective of the values system in England and of the National Health System, and thus, is it responsible for the disproportionate rate of deaths due to cancer among older persons? Perhaps it is not age bias alone driving the poor health outcomes of older cancer patients, but maybe patients are choosing not to receive screening and non-standard treatments and clinicians are choosing not to offer these healthcare options due to the high rate of comorbidities and low life expectancies within this patient population.

The salient issue here is not whether older patients are receiving cancer screenings and treatment offered their younger counterparts, but whether they may actually benefit from these procedures. Would a frail 78-year-old woman with urinary incontinence and moderate cognitive impairment benefit from a mammography? Is age a discriminating factor associated with preventable deaths among older cancer patients?

The answers to these questions vary, depending on the source. The literature on benefits and burdens of cancer screening and treatment in older persons is contradictory at best. Below is a sampling of a handful of studies presenting diverse perspectives on the issue:

  • A 2001 U.S. retrospective observational study showed that among 216 older women (mean age of 81 years) receiving mammographies, only 2 (0.9%) may have benefited from the screening. 42% experienced pain or psychological distress as a result of the mammographies.

  • A 2007 systematic review by researchers in Switzerland suggests that older cancer patients with breast or gynecologic cancers are often undertreated, the effect of which is decreased prognosis. Age and comorbidities were found to be determining factors for undertreatment in older patients, with reportedly few studies actually focusing on the health effects of undertreatment.

  • A 2007 literature review from Italy looking at the correlation between colonoscopy and life expectancy found that although the rate of colorectal polyps detection in patients 80 and older was higher (29%) than the 50-54 (14%) and 74-79 (27%) age groups, life expectancy gain was smaller in the oldest age group (one and a half months compared to 10 months in the youngest age group).

  • A 2008 observational study from Spain found that among older patients with non-small cell lung cancer co-morbid conditions was more important than age in influencing treatment options.

    After reading these articles and several others of similar topic, the resounding bottom line seems to be that it is more important to focus on individualized geriatrics care than to generally promote screenings and non-standard treatments for older cancer patients.

    Findings from the King’s Fund cancer report will serve to galvanize the British government to improve geriatrics care, especially as it pertains to cancer screening and treatment for older persons. However, the question remains, will these efforts to endorse cancer screening and treatment among older persons outweigh the negative effects in practice?

By: Julie N. Thai [GeriPal International Correspondent]


Popular posts from this blog

Practical Advice for the End of Life: A Podcast with BJ Miller

This week we talk with BJ Miller, hospice and palliative care physician, public speaker, and now author with Shoshana Berger of the book "A Beginner's Guide to the End."

As we note on the podcast, BJ is about as close as we get to a celebrity in Hospice and Palliative Care.  His TED Talk "What Really Matters at the End of Life" has been viewed more than 9 million times.  As we discuss on the Podcast, this has changed BJ's life, and he spends most of his working time engaged in public speaking, being the public "face" of the hospice and palliative care movement.

The book he and Berger wrote is filled to the brim with practical advice.  I mean, nuts and bolts practical advice.  Things like:
How to clean out not only your emotional house but your physical house (turns out there are services for that!)Posting about your illness on social media (should you post to Facebook)What is the difference between a funeral home and mortuaryCan I afford to die?  …

Improving Advance Care Planning for Latinos with Cancer: A Podcast with Fischer and Fink

In this week's GeriPal podcast we talk with Stacy Fischer, MD and Regina Fink, RN, PhD, both from the University of Colorado, about a lay health navigator intervention to improve advance care planning with Latinos with advanced cancer.  The issue of lay health navigators raises several issues that we discuss, including:
What is a lay health navigator?What do they do?  How are they trained?What do lay health navigators offer that specialized palliative care doesn't?  Are they replacing us?What makes the health navigator intervention particularly appropriate for Latinos and rural individuals?  For advance care planning? Eric and I had fun singing in French (yes French, not Spanish, listen to the podcast to learn why).
Enjoy! -@AlexSmithMD

You can also find us onYoutube!

Listen to GeriPal Podcasts on:
iTunes Google Play MusicSoundcloudStitcher


Eric: Welcome to the GeriPal podcast. This is Eric Widera.

Alex: This is Alex Smith.

Eric: And Alex, I'm really excited about toda…

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …